Landos Biopharma’s Phase 2 Data of Omilancor in Ulcerative Colitis Accepted for Oral Presentation at the United European Gastroenterology Week 2021

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs